These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8219985)

  • 21. [Experimental arrhythmia and its prevention].
    Stazhadze LL; Ventslavskaia TA; Korzhova VV
    Kosm Biol Aviakosm Med; 1985; 19(6):64-8. PubMed ID: 4087865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical experiences with an antiarrhythmic drug combination].
    Klinnert U
    Med Welt; 1972 Dec; 23(49):1878-80. PubMed ID: 4566977
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative characteristics of the antiarrhythmic activity of lidocaine, trimecaine and pyromecaine].
    Orlov VM; Ivashchuk AG; Iartsev SS; Meshcheriakova NK; Tkhu FT
    Sov Med; 1984; (3):82-4. PubMed ID: 6719244
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of supraventricular tachyarrhythmias.
    Aronow WS
    Compr Ther; 1989 Apr; 15(4):11-6. PubMed ID: 2650980
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiarrhythmic drugs.
    Campbell RW
    Practitioner; 1981 Oct; 225(1360):1445-9. PubMed ID: 7329933
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current anti-arrhythmic treatments and drugs].
    Chiche P; Witchitz S; Naouri L; Philippe B
    Coeur Med Interne; 1973; 12(1):129-44. PubMed ID: 4146955
    [No Abstract]   [Full Text] [Related]  

  • 27. Papaverine as an antiarrhythmic agent.
    Whipple GH
    Angiology; 1977 Nov; 28(11):737-49. PubMed ID: 333993
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of anti-arrhythmia agents on ventricular arrhythmias arising as a consequence of disorders in the myocardial blood supply].
    Gendenshteĭn EI; Kostin IaV; Markelova NN; Balashov VP; Oleĭnikov VE; Perevarin AV
    Farmakol Toksikol; 1990; 53(4):28-30. PubMed ID: 2226754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiarrhythmic action of certain 1,5-diphenyl-bispidin derivatives].
    Cartoni C; Figini A; Carpi A
    Ann Ist Super Sanita; 1968; 4(3):333-5. PubMed ID: 5734619
    [No Abstract]   [Full Text] [Related]  

  • 30. Observations on models used for the evaluation of antiarrhythmic drugs.
    Baum T; Eckfeld DK; Shropshire AT; Rowles G; Varner LL
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):149-70. PubMed ID: 5111320
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
    Terhaag B; Förster W
    Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
    [No Abstract]   [Full Text] [Related]  

  • 32. [Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats].
    Sokhanenkova AE; Sokhanenkov MIu; Afanas'eva EIu; Arzamastsev EV
    Kardiologiia; 2008; 48(6):57-61. PubMed ID: 18729838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-arrhythmic properties of ethmosine (clinico-experimental study)].
    Kaverina NV; Senova ZP; Lyskovtsev VV
    Kardiologiia; 1978 Apr; 18(4):67-72. PubMed ID: 671970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of obsidan, isoptin, procaine amide and quinidine in the treatment of various types of arrhythmia].
    Chizh VD
    Vrach Delo; 1977 Oct; (10):64-6. PubMed ID: 602135
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effectiveness of trimecaine, a new anti-arrhythmia agent].
    Gendenshteĭn EI; Ganelina IE; Kostin IaV; Kukuĭ LM; Tsybusov AP
    Klin Med (Mosk); 1980 Jun; 58(6):47-50. PubMed ID: 7401603
    [No Abstract]   [Full Text] [Related]  

  • 36. [Various aspects of the anti-arrhythmia action of trimecaine and its effect on hemodynamics].
    Kostin IaV; Oleĭnikov VE; Sernov LN; Tatarchenko IP; Gendenshteĭn EI
    Farmakol Toksikol; 1984; 47(1):47-50. PubMed ID: 6200357
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of a combination of N-propylajmaline bromide and trimecaine on heart arrhythmias of different origins and on the electrophysiological parameters of the myocardium].
    Gendenshteĭn EI; Balashov VP; Sosunov EA; Kostin IaV; Oleĭnikov VE
    Farmakol Toksikol; 1991; 54(4):30-3. PubMed ID: 1786818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions.
    Yamada K; Shimamura T; Nakajima H
    Jpn J Pharmacol; 1973 Jun; 23(3):321-8. PubMed ID: 4146776
    [No Abstract]   [Full Text] [Related]  

  • 39. [Role of surface phenomena in the mechanism of action of antiarrhythmic substances].
    Prianishnikova NT; Samvelian VM; Diadiura ZhA
    Biull Eksp Biol Med; 1976 Dec; 82(12):1451-3. PubMed ID: 1023973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cardiac antiarrhythmic screening test in the rat: the effects of lidocaine, propranolol and quinidine.
    Baker T; Erker EF
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):97-102. PubMed ID: 7387264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.